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Background/aims: This study’s objective was to evaluate a patient-centered educa-
tional electronic tablet application, “My Interventional Drug-Eluting Stent Educational 
App” (MyIDEA) to see if there was an increase in patient knowledge about dual antiplatelet 
therapy (DAPT) and medication possession ratio (MPR) compared to treatment as usual.
Methods: In a pilot project, 24 elderly (≥50  years old) research participants were 
recruited after a drug-eluting stent. Eleven were randomized to the control arm and 
13 to the interventional arm. All the participants completed psychological and knowl-
edge questionnaires. Adherence was assessed through MPR, which was calculated at 
3 months for all participants who were scheduled for second and third follow-up visits.
results: Relative to control, the interventional group had a 10% average increase in 
MPR. As compared to the interventional group, more patients in the control group had 
poor adherence (<80% MPR). The psychological data revealed a single imbalance in 
anxiety between the control and interventional groups. On average, interventional partic-
ipants spent 21 min using MyIDEA.
Discussion: Consumer health informatics has enabled us to engage patients with their 
health data using novel methods. Consumer health technology needs to focus more 
on patient knowledge and engagement to improve long-term health. MyIDEA takes a 
unique approach in targeting DAPT from the onset.
conclusion: MyIDEA leverages patient-centered information with clinical care and the 
electronic health record highlighting the patients’ role as a team member in their own 
health care. The patients think critically about adverse events and how to solve issues 
before leaving the hospital.
Keywords: mobile health, patient-centered research, health informatics, Kolb learning theory, consumer health 
informatics
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inTrODUcTiOn
Patient antithrombotic medication adherence following place-
ment of a drug-eluting stent (DES) is a challenge as 5.4% of 
patients never fill a prescription and on average, patients have 
their medication only 81% of the time over a year (1). Non-
adherence to antithrombotic medication leads to a nine times 
greater risk of death within the first year of the stent placement 
(2–5). Failure to adhere to the medication regimen for DES is 
associated with an increase of 20–40% in mortality rate (3, 4, 6, 
7). Secondary prevention of future disease and disability requires 
patients understanding about the importance of medication 
adherence; non-adherence is often due to frequent miscom-
munication between the medical staff and patients regarding the 
purpose of the medication or the specific duration of medication 
(8, 9).
This gap indicates that health-care education research is 
needed to improve patient-centered medical care (2, 8). We 
aimed to address this gap by creating an educational applica-
tion that would allow for patient centeredness by involving 
both patients and medical partners in building the program. 
Patient-centered outcomes research (PCOR) is used to improve 
patient education and treatment (10). PCOR focuses on gaps in 
knowledge and variation in patient care (10). Our study adhered 
to PCOR methodology standards: (1) we prioritized the research 
questions, (2) used an appropriate study design, (3) used patient 
perspectives, and (4) fostered efficient dissemination of the 
results (11).
While PCOR is critical to improve patient health, learning 
theories can help structure education to the learning needs 
of patients while being mindful of their learning styles (11). 
Kolb’s experiential learning theory is a four part cyclical model 
addressing four types of learning styles: converger, diverger, 
assimilator, and accommodator. Kolb’s four-stage learn-
ing cycle shows how experience is translated into concepts 
(12). The four stages include concrete experience, reflective 
observations, abstract conceptualization, and active experi-
mentation (12). Kolb’s model has been successfully applied to 
develop a number of patient, medical, and nursing education 
materials (13–20). PCOR can be improved by mobile health 
technology (MHT), which has been shown to lower health-
care costs and improve patient’s health (21, 22). MHT has 
been used extensively in studies of diabetes and other chronic 
diseases (23–31). A few studies have evaluated usage of cell 
phone reminders and online learning modules with differing 
results (24, 27, 29).
My Interventional Drug-Eluting Stent Education App 
(MyIDEA) was developed with a participatory design to provide 
a user centered educational intervention (32). This electronic 
tablet application is tailored to patients by utilizing personal-
ized data from their coronary revascularization procedure. 
Patient’s symptoms are integrated in the application. MyIDEA 
then prompts the patient to respond to how their symptoms 
have affected their lives ensuring reflective observation. The 
aim of this study was to test feasibility and recruitment and 
to see if there is any positive effect on medication possession 
ratio (MPR).
MaTerials anD MeThODs
A pilot study used a randomized control trial to measure a 
change in patient antithrombotic medication adherence. The 
study was conducted at the University of Illinois Hospital 
and Health Sciences System (UIH) and approved by the IRB. 
Participants were eligible if they met the following criteria (1) 
had a percutaneous coronary intervention with a DES at UIH, 
(2) understood English, and (3) were at least 50 years old (due 
to funding agency requirement). Exclusion criteria included 
an allergy to aspirin, thienopyridines (clopidogrel/ticagrelor/
prasugrel), and the inability to give informed consent. All 
subjects gave informed consent with the recommendations of 
the Belmont Report as approved by the University of Illinois 
Institutional Review Board (IRB).
The eligible patients were approached 2–4 h after placement 
of the DES and consented after understanding the risks and 
benefits. The research nurses administered the Rapid Estimate 
of Adult Literacy in Medicine-Short Form (REALM-SF) (33) 
to the consented participants to measure their health literacy, 
the 36-Item Short Form Health Survey (SF-36) (34), Hospital 
Anxiety and Depression Scale (HADS) (35), Burden–benefit 
questionnaire (36), and PCI knowledge questionnaire. The pur-
pose of the psychometric data was to compare the two groups. 
Randomization occurred upon enrollment, and the psychomet-
rics will reveal if the two groups were randomized equally on 
common psychometric factors affecting medication adherence. 
Next, the participants were randomized to either usual care (con-
trol arm) or MyIDEA (intervention arm). The participants in the 
interventional arm completed the educational program while the 
control arm received usual care that included informal education 
and used the tablet to play games of checkers and tic-tac-toe. All 
research participants were scheduled for a second appointment 
with the research team at their follow-up visit with cardiology 
following the procedure. The interventional group again inter-
acted with the MyIDEA program and all research participants 
completed the SF-36, HADS, and PCI knowledge questionnaire a 
second time. A third visit with the research team was scheduled 
at 3 months after their first visit date to complete the surveys. At 
all three visits, a blood draw was performed to measure aspirin 
reactive unit (ARU) and P2Y12 reaction unit (PRU). The blood 
tests measured platelet reactivity of both the Aspirin pathway and 
the P2Y12 protein. A company called VerifyNow produces two 
tests that measure the ARU and thienopyridine inhibitors, and 
it is measured as PRU (37). The research participants consented 
to have their pharmacies contacted to see when and how many 
prescriptions were filled for a thienopyridine inhibitor of the 
P2Y12 receptor.
A measure used to evaluate effectiveness of the tablet-based 
application was MPR. MPR is defined as the percentage of time 
that a patient has access to medication (38). It is calculated as 
the ratio of the research participant’s days’ supply of a specific 
medication to the number of days in the set time period. A MPR 
of 100% means the patient has enough medication to follow the 
desired prescription. Any value greater than or equal to 80% 
reflects good adherence (39). MPR was calculated from the day 
of consent to 90 days after enrollment. Some research participants 
FigUre 1 | images from the MyiDea educational application.
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were previously on a thienopyridine inhibitor, so refill dates less 
than 30 days before enrollment were included in the calculation 
of MPR. Comparison of the MPR difference between the drop out 
participants and those who attended visits 2 and 3 was conducted. 
Another measure to evaluate medication adherence involved 
blood tests of the platelet reactivity of both the ARU and PRU 
(37). These tests measure the effects of antiplatelet activity on two 
specific pathways separately. The equations used for obtaining 
this score were:
• ARUXPRU score = (ARU calculation × PRU calculation);
• ARU calculation =  (ARU upper reference value −  follow-up 
ARU)/(ARU upper reference value − ARU floor);
• PRU calculation =  (PRU upper reference value −  follow-up 
PRU)/(PRU upper reference value − PRU floor).
The MyIDEA application taught the importance of adherence 
to medication. As part of the NCDR Cath PCI 4.41 reporting 
template, patient symptoms such as heart attack, unstable angina, 
stable angina, shortness of breath, and fatigue were recorded. 
1 American College of Cardiology. NCDR Elements and Definitions. (2008). 
Available from: http://cvquality.acc.org/~/media/QII/NCDR/Data%20Collection% 
20Forms/CathPCI%20Registry_DataCollectionForm.ashx.
They were then taken from the report and tailored to the patient 
in MyIDEA. Another area of tailoring was to show the patients’ 
stent placement, a screen with information about the patients’ 
cardiologist and artery blockage pre- and post-op (Figure  1C) 
as well as his/her prescription (Figure  1B). By doing this, the 
patients were able to learn about their procedure and how the 
DES worked with the antithrombotic medication.
The program integrated active learning to engage patients 
to think critically about circumstances that could be detri-
mental to their drug adherence by using five patient stories 
designed to highlight peer reviewed causes of poor adherence 
(Figures  1A,D). Each story portrayed a real life situation to 
which the participants could relate by focusing on common 
challenges to adherence. They had themes such as monetary 
restrictions, family living too far away, outside influences alter-
ing their medication regime, and side effects of the medication. 
The patients answered questions regarding the scenarios, which 
actively engaged them in Kolb’s experiential learning theory. 
There was use of concrete examples with the patient stories. 
Also, participants used reflective observation and chose which 
story they most related to. Abstract conceptualization was used 
to learn about the importance of DES, what the medication 
did, why medication was needed daily for a year, and medica-
tion adherence. Last, active experimentation about how other 
TaBle 1 | Demographics of the research participants, with age, gender, race, ethnicity, and reading level.
Demographics all control My interventional Drug-eluting 
stent educational app
P-value
Age Mean (SD) 60.5 (7.0) 60.6 (4.1) 60.5 (8.9) 1
Gender Male 14 (58%) 7 (64%) 7 (54%) 0.70
Female 10 (42%) 4 (36%) 6 (46%)
Race White 6 (25%) 3 (27%) 3 (23%) 1
Black 15 (63%) 7 (64%) 8 (62%)
Asian 2 (8%) 1 (9%) 1 (8%)
Multirace 1 (4%) 0 (0%) 1 (8%)
Ethnicity Hispanic 3 (13%) 2 (18%) 1 (8%) 0.58
Non-Hispanic 21 (88%) 9 (82%) 12 (92%)
Reading level 4–6 1 (4%) 0 (0%) 1 (8%) 0.10
7–8 12 (50%) 8 (73%) 4 (31%)
9+ 11 (46%) 3 (27%) 8 (62%)
Medication pickup assistance Patients who had assistance picking up medication 18 (75%) 8 (73%) 10 (77%)
Number of individuals who had assistance picking up medication out of 24 total participants.
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patients overcame relatable obstacles helped patients apply the 
information to themselves.
The MyIDEA program assigned a time stamp to every click 
in the application as the participants advanced through the 
program; therefore, the amount of time spent on each of the 
screens by each participant could be calculated. The program 
was run listening to the audio of each screen to measure a total 
time to view the program without additional time for replays. A 
subgroup analysis was calculated to find the average percent of 
time spent by all the participants per screen during visit 1 and 
2 (Figures  1A–D). Screens 14–16, 18, and 19 are focused on 
patient-centered data and audio recordings and screens 34–38 
are the patient stories.
A multidisciplinary team and patient advocates conducted the 
analysis of the initial findings and engaged in a discussion about 
the results.
resUlTs
Twenty-four participants were recruited and 13 were randomized 
to the intervention. Thirty declined participation and 50 were 
ruled ineligible. The participants in this study were on average 
60.5 years old (SD 7.0 years) (see Table 1). Of the participants, 
58% were males and 42% were females. The grade reading 
level of the participants was 4% 4th–6th grade, 50% at 7th–8th 
grade, and 46% greater than 9th grade via REALM-SF (33). Of 
the participants, 63% were African-American, 25% White, 8% 
Asian, 4% were categorized as more than one race, and 13% were 
of Hispanic ethnicity. The 75% of participants (73% of control and 
77% of MyIDEA) had medication assistance (friends or family 
members who could help pickup the prescriptions).
Data were collected for 24 participants for visit 1, and 13 
participants for visit 2 in this study. Eight participants in the 
interventional arm attended visit 2, but the psychological ques-
tions and the blood test were missed for one participant. Of the 
12 research participants who did not complete visit 2, six had 
scheduled appointments and did not show and six could not be 
reached. There were 13 research participants who did not show 
up to their third visit because 8 could not be reached and 5 did 
not show.
The MPR was higher in the interventional group (0.95) than 
the control group (0.85) (see Table 2). The percentage of people 
who were adherent was numerically higher in the interventional 
group than the control (85 versus 64%), but the study was 
designed as a pilot and not for statistical significance. Evaluation 
of MPR was performed to see if there were differences by who 
did and did not drop out of the study. The MPR for the research 
participant in the interventional arm that appeared for visit 2 had 
a higher MPR (Table 2).
Examining the two groups for differences revealed the control 
group was significantly more anxious at 8.8 from the HADS 
compared to the intervention group 4.2 (see Table 3). However, 
on the emotional scales of the SF-36, both groups appear to be 
about the same (see Table 3).
When evaluating the biological measure of medication 
adherence between the two groups, the ARUXPRU score for 
visits 2 and 3 was lower for MyIDEA (Table S1 in Supplementary 
Material). An ARU and PRU value of 1 would indicate good 
adherence and 0 would be stopping the medication, with a value 
between the 0 and 1 related to the blood values of the Verifynow 
ARU and PRU tests. Due to limited follow-up by the research 
participants’ additional conclusions from these data were not 
warranted. In evaluating the beliefs about medication adherence 
between the two groups, the Morsiky-8 adherence questionnaire 
was approximately equivalent between the two groups (Table S2 
in Supplementary Material).
For the individuals randomized to the interventional arm, we 
calculated the average time spent on the MyIDEA application 
for the first visit was approximately 20:42 min (SD = 8:26) and 
approximately 19:21 min (SD =  9:47) for the second visit. The 
average first visit time for all participants who appeared for their 
second visit was 13:19 min (SD = 1:35).
During visit 1, seven participants recorded that they related 
to Frank’s story (financial challenges), four for Eva (side effects) 
TaBle 3 | Baseline: the hospital anxiety and Depression scale (haDs) scores and the sF-36 for both groups at visit 1.
Psychometric data
haDs control (n = 11) My interventional Drug-eluting stent educational app (Myidea) (n = 13) P-value
Anxiety 8.8 (5.2) 4.2 (3.4) 0.02
Depression 5.4 (2.4) 4.8 (2.2) 0.54
sF-36 scale control (n = 11) Myidea (n = 13) P-value
Physical function 41.4 (32.6) 44.2 (28.3) 0.82
Role limitation (physical) 31.8 (40.5) 42.3 (35.9) 0.51
Role limitation (emotional) 75.8 (42.4) 59.0 (43.4) 0.35
Fatigue 42.3 (21.3) 49.2 (26.2) 0.48
Emotional well-being 72.7 (17.3) 81.5 (17.3) 0.23
Social function 60.2 (30.0) 55.8 (34.5) 0.74
Pain 53.9 (32.7) 53.5 (29.6) 0.98
General health 50.0 (19.0) 47.3 (18.7) 0.73
P-values were obtained using independent t-tests. HADS scale: 0 corresponds to low depression and anxiety and 10 corresponds to high depression and anxiety. Comparison of 
SF-36 results between the two groups. Due to high attrition rates for visit 2 and 3, group comparisons are not shown for those visits. Numbers in parentheses are SDs.
TaBle 2 | The medication possession ratio (MPr) of the control and interventional group, and the percentage of patients who has MPr <80%.
MPr
control (n = 11) My interventional Drug-eluting stent educational app (Myidea) 
(n = 13)
P-value
MPR (mean ± SD) 0.85 ± 0.24 0.95 ± 0.22 0.27
Poor adherence 36% 15% 0.36
MPr for all consented participants MPr (mean, sD)
Control Dropped out at visit 2 0.86 (0.30)
Did not drop out at visit 2 0.84 (0.20)
MyIdea Dropped out at visit 2 0.87 (0.28)
Did not drop out at visit 2 1.03 (0.13)
P values were obtained using independent t-test and Fisher’s test. MPR for all consented participants: MPR by drop out at visit 2. Numbers in parentheses are SD. The MPR is 
greater than one due to the impact of filling the medication a few days early increasing the sum of day’s supply.
TaBle 4 | retention questionnaire showing the number of correct 
answers per visit for all participants.
retention and knowledge questionnaire
interventional group control group
Visit 1 Visit 2 Visit 1 Visit 2
Average 7.53 (1.45) 8.33 (1.70) 7.50 (1.12) 7.50 (0.87)
5
Shah et al. MyIDEA
Frontiers in Public Health | www.frontiersin.org December 2016 | Volume 4 | Article 272
and one for Heather (visiting family) and one unrecorded. 
In visit 2, five participants related to Eva’s story, two Frank’s, one 
did not respond. A small increase knowledge was demonstrated 
in the interventional arm at visit 2 compared to the control group 
(Table 4). 
DiscUssiOn
This phase 1 pilot study focused on acceptability and usage of 
MyIDEA, a tailored, multi-educational style electronic tablet-
based application for patient education. This study showed its 
potential and some of the challenges of conducting studies in 
the target population. The positive improvement in MPR for the 
intervention group compared to the control arm is promising, 
but further study is needed to determine if the effect measured is 
reproducible and sustained for a year, the duration of the therapy. 
Missing data from missed visits were substantial in this small 
study and indicate that additional resources will be needed to 
assist participants to complete study visits, perhaps with home 
visits or data collection over telephone.
Medication Possession ratio
In examining the differences in MPR, we evaluated the MPR in 
each arm by attendance at the second visit. Research participants 
in the interventional arm who attended the second visit had a 
higher MPR than those who did not attend visit two. This trend 
was not seen in the control group (Table 2). The ARU calcula-
tion in the interventional arm is less than the control arm. ARU 
calculation is dependent on attendance at visit two. Additional 
study is required to measure medication adherence for over the 
counter medication without prescription refills for ARU values. 
Factors such as automatic refills and 3-month prescription refills 
can also inflate MPR values. In addition, access to medication 
is not the same as taking the medication. In a prior study in the 
Veterans Affairs Hospital, a block away from where this study was 
conducted, 20.3% of patients were non-adherent (40) However, in 
6Shah et al. MyIDEA
Frontiers in Public Health | www.frontiersin.org December 2016 | Volume 4 | Article 272
the VA population, most of the medication is provided for little 
to no cost.
MyiDea Utilization
Analysis of the interventional arm about the usage of the 
MyIDEA program reveals in which sections of the program the 
patients spent the most time. We were able to use data tailored to 
each participant to augment the data provided by the clinicians 
about the procedure to show patients how-to problem solve issues 
such as monetary restrictions, transportation issues, and family 
support. The participants spent more time on the patient stories 
in their first visit than in their second visit, perhaps because they 
knew what to expect in visit 2.
The story patients most related to was Frank’s story. Frank’s 
story was related to monetary issues that kept him from getting 
his medication. This is consistent with the low-resource patient 
population served by the recruitment institution. The ways to 
help problem solve this issue was to rely on family and friends, 
have a good support system and always ask for help or talk to the 
physician about monetary restrictions.
comparison to Medication interventions
Indeed, there are many mobile health developments that have 
recently hit the market, but these products and applications 
merely focus on improving adherence without really targeting the 
root of the problem in the first place. MyIDEA aims to intervene 
before the patient begins their prescription regimen, whereas 
other solutions only begin their intervention after the patient 
begins their medication. For example, GlowCap© uses a modi-
fied prescription bottle cap to remind users when to take their 
pills2. While the company states that they target the adherence 
issue of poor education, they only do so by weekly emails that 
are sent to the user after they begin using the product. However, 
there is no guarantee that users will thoroughly look through the 
email or even open it, which limits this aspect of the educational 
engagement of GlowCap. Similar approaches to solving adher-
ence include the Kraken Medication Management system©3. This 
system tries fixing the problem by raising adherence rates but 
does not target poor education with medication adherence. Even 
smartphone applications, such as Mango Health, are trying to 
target the problem of poor adherence4. The app works by sending 
reminders to users and rewarding them with incentives if they take 
their medication. However, this system can be easily exploited as 
patients can say they are taking their medication without doing so 
and receive the rewards. Thus, MyIDEA takes a unique approach 
in that it is targeting the problem from the onset. MyIDEA aims 
to improve patient education before beginning a medication and 
engages participants without the requirement of a smartphone. 
MyIDEA, in other words, aims to improve medication adherence 
from a more preventative standpoint in comparison to current 
mobile health solutions.
2 Glow Caps. (2015). Available from: http://www.vitality.net/research.html.
3 Kraken. (2015). Available from: http://www.impakhealth.com/medication-monitoring.
4 Mango Health. (2015). Available from: https://www.mangohealth.com/about.
html.
limitations and strengths
This is a single hospital with an enrollment of 24 research partici-
pants. One of the challenges with the MPR is that four research 
participants received a 90-day refill of their prescription, which 
when following research participants for 3 months would ensure 
a high MPR. Of the four participants, three of them were in the 
interventional group and one was in the control group. Response 
bias in the psychological tools is possible since the research 
participants would not want to let their physician down.
implications for Theory, research,  
and Practice
Customer interactions with Amazon, Google, and all other 
technology are customized based on prior interactions with 
these companies. Customization has been driving innovation 
in many fields outside of medicine and is user friendly with an 
easy to understand format. This same idea can be transferred 
to the field of medicine for an easy-to-use learning application. 
The Kolb’s experiential learning theory is flexible enough for 
novel interventions that combine data recorded by clinicians, 
dynamic visualizations, and interactions with mobile technology. 
In this study, we use this theory to improve medication adher-
ence. Participants are able to work with their own information 
in a user friendly format. In patient education, we should aim 
to integrate and customize the education to existing data within 
the Electronic Health Record to meet the unique needs of the 
patient condition. This customization will cater to different forms 
of learning that is suitable to most users. Additional research with 
MyIDEA and other customized educational tools is needed to 
evaluate if impact is similar.
cOnclUsiOn
Future studies should focus on whether MyIDEA is creating a 
positive difference in medication drug adherence compared 
with treatment as usual. There is an ongoing discussion about 
non-inferiority of 6- versus 12-month DAPT with respect to the 
primary end point target lesion failure in a cohort of patients 
undergoing DES (41). There is currently not a definitive answer 
about differences between lengths of DAPT treatment, but all rec-
ommendations are dependent on the patient adherence, which 
MyIDEA has demonstrated to improve. Results from this study 
will enable new and effective educational programs to increase 
medication adherence as well as patient knowledge about the 
procedure that was performed on each participant. From the data 
obtained, we observed that the patients spent a larger percentage 
of time on patient stories, focusing on problem solving issues 
and critically thinking about solutions. Patient-centered health 
information used with an educational application is proving to 
be useful and progressive toward increasing drug adherence for 
patients. mHealth is promising but the technology needs to be 
developed to address the causes of poor medication adherence 
and not just technology to measure adherence. In the future, 
educational applications with the same concept as MyIDEA 
pertaining to other areas of medicine may also prove to be an 
effective way to engage patients.
7Shah et al. MyIDEA
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